Gallivan Theresa (002)
This speaker appears at this event:

This speaker’s events are being finalized

Theresa Gallivan, RN

    • Associate Chief Nurse, MGH

Theresa Gallivan RN, MS, NEA-BC, is Associate Chief Nurse for Medicine, Emergency, and Heart Center Nursing at Massachusetts General Hospital (MGH).

Theresa’s primary areas of focus are leadership development; interdepartmental and inter-professional planning and coordination; continuous process improvement and process redesign; patient-and family-focused care; and the professional practice environment. Theresa oversees and collaborates with Nursing Directors, Clinical Nurse Specialists, Nursing Practice Specialists, and staff spanning 23 clinical settings and more than 1500 nursing FTEs.

When asked about programs or outcomes of which she is most proud, Theresa speaks to the caliber of nursing leadership she has established; the quality, satisfaction, financial and human resource outcomes achieved; and the credibility that she and her leadership team holds with other discipline colleagues, departments and services throughout the organization. Building upon the caliber of leadership candidate the MGH attracts, Theresa invests in leadership recruitment, selection, onboarding, and development. Theresa and physician colleague Hasan Bazari MD, were co-awarded the prestigious Nathaniel Bowditch Award for leadership to improved care coordination, improved care quality, and reductions in length of stay in Medicine. The Massachusetts Association of Registered Nurses (MARN) named Theresa the recipient of the Mary A. Manning Nurse Mentoring Award for authentic leadership and role-modeling, enabling others to move forward to establish innovative clinical programs, to lead national studies and to achieve executive level administrative positions. Theresa has also been awarded the Champions in Healthcare Award, by the Boston Business Journal for her work in developing future nurse leaders in healthcare, and is the recipient of numerous Partners in Excellence Awards for individual outcomes, as well as that of team-led initiatives.

Gene and Cell Therapy

May 10–12, 2021